Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinomaMaria J. De Herdt, Leendert H. J. Looijenga|Oncotarget|2016Cited by 17
The Potential of MET Immunoreactivity for Prediction of Lymph Node Metastasis in Early Oral Tongue Squamous Cell CarcinomaMaria J. De Herdt, José A. Hardillo|Frontiers in Oncology|2021Cited by 7